To investigate whether metformin is capable to regulate the activity of TGF-β signaling through targeting INHBA, we treated CRC cells with metformin and found the phosphorylation level of Smad2 was decreased in all cells receiving metformin treatment (Fig. 6f). The gene discussed is TGFB1; the disease is colorectal carcinoma.